Hi-Tech Pharmacal third-quarter revenues up 18% with "strong" sales from branded OTCs.
This article was originally published in The Tan Sheet
Executive Summary
HI-TECH PHARMACAL THIRD-QUARTER SALES RISE 18% to $4.7 mil. for the period ended Jan. 31. The company attributed the increase to "strong sales" by its Health Care Products division and a contribution from Rose Labs, which was acquired in November 1994. The Health Care division sells company-brand OTCs under the H-T, Sooth-It and Diabetic Tussin brands. Rose Labs manufactures private-label suppository products ("The Tan Sheet" Nov. 7, 1994, In Brief)